Rapid Micro Reports Q2 Revenue Growth and Margin Expansion
Rapid Micro Biosystems reported 11% Q2 revenue growth to $8.1M and record gross margins. The company reaffirmed full-year guidance, highlighting strong recurring revenue and 200th system milestone.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day